Follow
Rajendra Bahadur Shahi
Rajendra Bahadur Shahi
Bioinformatics Scientist at eTheRNA immunotherapies
Verified email at vub.be - Homepage
Title
Cited by
Cited by
Year
Neo-antigen mRNA vaccines
A Esprit, W de Mey, R Bahadur Shahi, K Thielemans, L Franceschini, ...
Vaccines 8 (4), 776, 2020
692020
Identification of candidate cancer predisposing variants by performing whole-exome sequencing on index patients from BRCA1 and BRCA2-negative breast …
RB Shahi, S De Brakeleer, B Caljon, I Pauwels, M Bonduelle, S Joris, ...
BMC cancer 19, 1-11, 2019
442019
The genomic landscape of nonsmall cell lung carcinoma in never smokers
B Boeckx, RB Shahi, D Smeets, S De Brakeleer, L Decoster, ...
International journal of cancer 146 (11), 3207-3218, 2020
332020
CRAF mutations in lung cancer can be oncogenic and predict sensitivity to combined type II RAF and MEK inhibition
A Noeparast, P Giron, A Noor, R Bahadur Shahi, S De Brakeleer, ...
Oncogene 38 (31), 5933-5941, 2019
272019
Antibacterial activities of medicinal plants of Nepal
K Pokharel, BR Dhungana, KB Tiwari, RB Shahi, BKYM Sharma, ...
Journal of Institute of Medicine 30 (2), 2009
152009
Detection of EGFR-TK domain–activating mutations in NSCLC with generic PCR-based methods
RB Shahi, S De Brakeleer, J De Greve, C Geers, E Teugels
Applied Immunohistochemistry & Molecular Morphology 23 (3), 163-171, 2015
132015
An exome-wide study of renal operational tolerance
A Massart, R Danger, C Olsen, MJ Emond, O Viklicky, V Jacquemin, ...
Frontiers in medicine 9, 976248, 2023
12023
Parp inhibitors
JD Grève, L Decoster, RB Shahi, C Fontaine, L Vanacker, I Pauwels, ...
Belgian Journal of Medical Oncology 10 (7), 263-275, 2016
12016
The clinical characteristics of breast cancers with a familial risk in which no BRCA1/2 mutations were found are sometimes suggestive for a genetic etiology
S Joris, RB Shahi, S De Brakeleer, C Fontaine, ML Bonduelle, P Ingrid, ...
Journal of molecular and genetic medicine 13 (2), 423, 2019
2019
A lung cancer-derived CRAF mutation to activate ERK pathway and to predict sensitivity to LY3009120 and trametinib.
A Noeparast, J De Greve, S De Brakeleer, R Bahadur Shahi, E Teugels
Journal of Clinical Oncology 35 (15_suppl), e23197-e23197, 2017
2017
Abstract PD7-04: Exome based germline mutation detection in a panel of 372 cancer associated genes in BRCA1/2-negative familial breast cancer patients
RB Shahi, B Caljon, S De Brakeleer, L Decoster, C Fontaine, L Vanacker, ...
Cancer Research 76 (4_Supplement), PD7-04-PD7-04, 2016
2016
Identification of candidate breast cancer predisposing genes by sequencing extended panel of 492 cancer associated genes in BRCA1/2 negative probands
RB Shahi, B Caljon, S De Brakeleer, L Decoster, C Fontaine, L Vanacker, ...
Identification of candidate breast cancer predisposing variants by performing whole
RB Shahi, S De Brakeleer, B Caljon, I Pauwels, M Bonduelle, S Joris, ...
The system can't perform the operation now. Try again later.
Articles 1–13